Accord Healthcare Launches Dehydrated Alcohol Injection for Cardiovascular Indications

RALEIGH, N.C., June 25, 2025 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Dehydrated Alcohol Injection to its line of cardiovascular drugs. Accord's product is AB-rated to BPI Labs' Ablysinol® and is offered in 99% 5mL vials.

Dehydrated Alcohol is approved by the FDA and is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy¹.

"The launch of Accord Healthcare's Dehydrated Alcohol Vials represents a meaningful advancement in offering a more convenient alternative to the traditional ampule market," said Chrys Kokino, President of Accord Healthcare US. "It reflects our ongoing commitment to improving access and efficiency for healthcare providers."

Important Safety Information

Transient heart block is common at the time of injection and is typically managed with the routine use of a temporary pacing wire. In approximately 10% of cases, complete heart block may become permanent, requiring a permanent pacemaker. The temporary pacing lead should be removed if no high-degree atrioventricular block occurs. Patients should be monitored for signs of heart failure, chest pain, and arrhythmias in the days following the procedure.

About Accord Healthcare US

Accord Healthcare, a wholly owned subsidiary of Intas Pharmaceuticals, is a leading generic pharmaceutical company. Accord Healthcare is committed to improving lives by increasing access to medicines while also providing novel solutions that enhance the pharmaceutical experience for both healthcare providers and patients. Accord Healthcare combines its advanced manufacturing technology with in-house research to produce highly complex, affordable, and essential medicines. Accord Healthcare's forward-thinking, innovative approach, and its resolve to help patients remains at the heart of everything they do. Accord Healthcare is headquartered in Raleigh, North Carolina. The Intas network markets its products in 80 countries. To learn more, visit the Accord Healthcare website.

References:

1. Dehydrated Alcohol Injection. Prescribing Information. Accord Healthcare; June 2025.

Media Contact:
Lauren Wheeler
Email: [email protected] 

SOURCE Accord Healthcare US